Evidence map›Paper›PMID 29881622›Full record

ArticleJournal of clinical urology2018

Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method.

D Thurtle, L Starling, K Leonard, T Stone, V J Gnanapragasam

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of clinical urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02375035 (Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02375035 unknown statusnot on this map

Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer

TypeobservationalSponsorCambridge University Hospitals NHS Foundation TrustRan2015 to 2019Enrolled50ConditionsProstate Cancer, Prostate BiopsyArmsCAMPROBE
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

D ThurtleAcademic Urology Group, University of Cambridge, Cambridge, UK.
L StarlingAcademic Urology Group, University of Cambridge, Cambridge, UK.
K LeonardAcademic Urology Group, University of Cambridge, Cambridge, UK.
T StoneMedical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, UK.
V J GnanapragasamAcademic Urology Group, University of Cambridge, Cambridge, UK.
University of Cambridge · GBAddenbrooke's Hospital · GB

Funding

Department of Health II-LB-0716-20001
6 · The paper itself

Abstract

objectivesThe aim of this study was to pilot the use of a bespoke device (CAMPROBE, the CAMbridge PROstate Biopsy) to enable routine outpatient free-hand local anaesthetic (LA) transperineal prostate biopsies. MATERIALS AND

methodsThe CAMPROBE prototype was designed and built in our institution. Men on active surveillance due prostate resampling were invited to have a CAMPROBE biopsy as an alternative to repeat transrectal ultrasound-guided prostate biopsies (TRUSBx) as part of an approved trial (NCT02375035). Biopsies were performed using LA infiltration only, without sedation or additional analgesia. Patient-reported outcomes were recorded at day 0 and 7 using validated questionnaires and visual analogue scales (VAS). Complications were recorded prospectively.

resultsThirty men underwent biopsies with a median of 11 cores taken per procedure (interquartile range 10-12). There were no infections, sepsis or retention episodes. Haematuria and haematospermia occurred in 67% and 62% of patients, which are similar to rates reported for TRUSBx. Mean VAS for pain (0-10 scale) was less than 3 for every part of the procedure. All 30 men described the procedure as tolerable under LA. In total, 26/30 (86.7%) men expressed a preference for a CAMPROBE procedure over TRUSBx and a further 3 (10.0%) would have either.

conclusionsIn this small pilot study, the CAMPROBE device and method appears to be a safe, simple and well-tolerated out-patient transperineal replacement for TRUSBx. A major new National Institute for Health Research grant will allow its further development from a prototype to a single use, low-cost disposable device ready for multi-centre testing. LEVEL OF EVIDENCE: 1b: individual cohort study.

Indexed as

diagnostic interventionpatient safetyProstate cancerservice deliverytransperineal biopsy

Identifiers

PMID29881622
PMCPMC5977271
OpenAlexW2790972939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.